EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma

Giuseppina Daniela Naimo, Giuseppe Cirillo iD, Manuela Curcio iD, Ludovica Scorzafave, Marco Fiore, Francesca Giordano, Antonella Leggio iD, Diana Amantea iD, Fiore Pasquale Nicoletta, Loredana Mauro, Francesca Iemma

Biomacromolecules · 09.11.2026 · 27 (11) · 7625-7639

DOI: 10.1021/acs.biomac.6c01684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 14.10.2026. Verfasst von Giuseppina Daniela Naimo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Health and Nutritional Science, University of Calabria, Rende (CS)87036, Italy. Hauptthemen laut MEDLINE: Doxorubicin, Glioblastoma, Nanoparticles, Drug Delivery Systems. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università della Calabria, Universit? della Calabria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We engineered a protein-based nanoplatform exploiting the intrinsic disulfide network of human serum albumin (HSA) to generate self-crosslinked, redox-responsive nanoparticles without synthetic crosslinking agents. Following folic acid conjugation, HSA nanoparticles (f-HNPs) were prepared by desolvation-assisted self-crosslinking and loaded with doxorubicin (DOX) with 88% encapsulation efficiency. The resulting nanoparticles were spherical, with an average diameter of 37 ± 5 nm and PDI of 0.24, and underwent glutathione-triggered destabilization and accelerated drug release under reducing conditions. Empty f-HNPs showed excellent biocompatibility, whereas DOX@f-HNPs enhanced DOX cytotoxicity against U-87MG glioblastoma cells, reducing the IC50 from 0.24 to 0.17 μg mL−1. Competitive inhibition experiments supported folate receptor-mediated uptake and enhanced intracellular drug accumulation. Nanoparticle-mediated delivery increased oxidative stress, mitochondrial depolarization, and G2/M cell-cycle arrest, accompanied by p21 upregulation, Cyclin D1 and Ki67 downregulation, and sustained inhibition of glioblastoma cell proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinGlioblastomaNanoparticlesDrug Delivery SystemsSerum Albumin, HumanHumansCell Line, TumorFolic AcidCell ProliferationDrug LiberationDrug Carriers

Stichwörter der Autor:innen

albumin nanoparticlesfolate targetingglioblastomaredox responsiveness

Substanzen

DoxorubicinFolic AcidSerum Albumin, HumanDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmacy Health and Nutritional Science, University of Calabria, Rende (CS)87036, Italy.

ORCID-Profile: Giuseppe Cirillo, Manuela Curcio, Antonella Leggio, Diana Amantea

Förderung

  • Università della Calabria
  • Universit? della Calabria

Zitieren

APA

Naimo, G. D., Cirillo, G., Curcio, M., Scorzafave, L., Fiore, M., Giordano, F., Leggio, A., Amantea, D., Nicoletta, F. P., Mauro, L., & Iemma, F. (2026). Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma. Biomacromolecules, 27(11), 7625-7639. https://doi.org/10.1021/acs.biomac.6c01684

Vancouver

Naimo GD, Cirillo G, Curcio M, Scorzafave L, Fiore M, Giordano F, et al. Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma. Biomacromolecules. 2026;27(11):7625-7639. doi:10.1021/acs.biomac.6c01684

BibTeX
@article{Naimo2026,
  author = {Naimo, Giuseppina Daniela and Cirillo, Giuseppe and Curcio, Manuela and Scorzafave, Ludovica and Fiore, Marco and Giordano, Francesca and Leggio, Antonella and Amantea, Diana and Nicoletta, Fiore Pasquale and Mauro, Loredana and Iemma, Francesca},
  title = {Self-Crosslinked Albumin Nanoparticles for Targeted Doxorubicin Delivery in Glioblastoma},
  journal = {Biomacromolecules},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {7625--7639},
  doi = {10.1021/acs.biomac.6c01684}
}
Kostenlos starten →